Analysis-Drug giants eye China for deals despite growing Sino-US tensions
By Andrew Silver and Kane Wu SHANGHAI/HONG KONG (Reuters) – Some of the biggest global drugmakers, undeterred by mounting Sino-U.S. tensions, are scouring for deals in China to replenish drug pipelines and boost their presence in the world’s second-biggest pharmaceutical market, industry executives and investment bankers said. Several major deals have already been completed this …
Analysis-Drug giants eye China for deals despite growing Sino-US tensions Read More »










